CDIO icon

Cardio Diagnostics
CDIO

Overview Fund Activity

15 hedge funds and large institutions have $152K invested in Cardio Diagnostics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.

Holders
15
Holders Change
+5
Holders Change %
+50%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TSS
1
Two Sigma Securities
New York
$11K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$6K
3
PCM
3
Prelude Capital Management
New York
$41.1K
4
HF
4
HRT Financial
New York
$3K
5
TRCT
5
Tower Research Capital (TRC)
New York
$3.3K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
PCM
1
Prelude Capital Management
New York
$41.1K 121,000 +11,000 +10%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$25.7K 75,483 – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$21.8K 64,022 – –
LA
4
Linden Advisors
New York
$15.5K 45,618 – –
PNC Financial Services Group
5
PNC Financial Services Group
Pennsylvania
$13.8K 40,500 – –
TSS
6
Two Sigma Securities
New York
$11K 32,245 +32,245 New
State Street
7
State Street
Massachusetts
$6.83K 20,100 – –
Renaissance Technologies
8
Renaissance Technologies
New York
$6K 17,800 +17,800 New
TRCT
9
Tower Research Capital (TRC)
New York
$3.3K 9,705 +4,155 +75%
HF
10
HRT Financial
New York
$3K 11,273 +11,273 New
CSC
11
Caldwell Sutter Capital
California
$2.75K 8,101 – –
WAM
12
Wolverine Asset Management
Illinois
$1.63K 4,788 – –
UBS Group
13
UBS Group
Switzerland
$21 61 +61 New
Wells Fargo
14
Wells Fargo
California
$16 47 +3 +7%
JPMorgan Chase & Co
15
JPMorgan Chase & Co
New York
$2 6 +6 New
CFGS
16
Concourse Financial Group Securities
Alabama
– – – –